(Q28373327)

2

0 references

L Ben-Arie

3

0 references

J K Krauss

4

0 references

R Grossman

Journal of the Neurological Sciences

5

0 references

language of work or name

English

0 references

publication date

1 August 1999

0 references

published in

0 references

volume

167

0 references

issue

1

0 references

page(s)

62-7

0 references

cites work

Impact of deprenyl and tocopherol treatment on Parkinson's disease in DATATOP patients requiring levodopa. Parkinson Study Group

1 reference

https://api.crossref.org/works/10.1016%2FS0022-510X%2899%2900141-0

Young onset Parkinson's disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-510X%2899%2900141-0

Risk factors for peak dose dyskinesia in 100 levodopa-treated parkinsonian patients

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-510X%2899%2900141-0

Levodopa-induced dyskinesias in Parkinson's disease: clinical and pharmacological classification

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-510X%2899%2900141-0

Wearing-off fluctuations in Parkinson's disease: contribution of postsynaptic mechanisms.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-510X%2899%2900141-0

L-DOPA reverses altered gene expression of substance P but not enkephalin in the caudate-putamen of common marmosets treated with MPTP

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-510X%2899%2900141-0

Chronic L-DOPA administration induces dyskinesias in the 1-methyl-4- phenyl-1,2,3,6-tetrahydropyridine-treated common marmoset (Callithrix Jacchus).

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-510X%2899%2900141-0

Levodopa-induced dyskinesias improved by a glutamate antagonist in Parkinsonian monkeys

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-510X%2899%2900141-0

Acute pharmacologic blockade of dyskinesias in Parkinson's disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-510X%2899%2900141-0

Leksell's posteroventral pallidotomy in the treatment of Parkinson's disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-510X%2899%2900141-0

Stereotactic ventral pallidotomy for Parkinson's disease.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-510X%2899%2900141-0

Treatment of advanced Parkinson's disease by posterior GPi pallidotomy: 1-year results of a pilot study

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-510X%2899%2900141-0

Posteroventral medial pallidotomy in advanced Parkinson's disease.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-510X%2899%2900141-0

Usefulness of pallidotomy in advanced Parkinson's disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-510X%2899%2900141-0

Efficacy, stability and predictors of outcome of pallidotomy for Parkinson's disease. Six-month follow-up with additional 1-year observations

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-510X%2899%2900141-0

Microelectrode-guided posteroventral pallidotomy for treatment of Parkinson's disease: postoperative magnetic resonance imaging analysis.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-510X%2899%2900141-0

Assessment of motor function after stereotactic pallidotomy.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-510X%2899%2900141-0

Movement and reaction times and fine coordination tasks following pallidotomy.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-510X%2899%2900141-0

Posteroventral medial pallidotomy in levodopa-unresponsive parkinsonism.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-510X%2899%2900141-0

Core assessment program for intracerebral transplantations (CAPIT)

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-510X%2899%2900141-0

Utility of an objective dyskinesia rating scale for Parkinson's disease: inter- and intrarater reliability assessment.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-510X%2899%2900141-0

Clinical rating of dyskinesias in Parkinson's disease: use and reliability of a new rating scale

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-510X%2899%2900141-0

Apomorphine responses in Parkinson's disease and the pathogenesis of motor complications.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-510X%2899%2900141-0

Hemiballism-hemichorea. Clinical and pharmacologic findings in 21 patients

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-510X%2899%2900141-0

Improvement of parkinsonian signs after vascular lesions of the basal ganglia circuitry.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-510X%2899%2900141-0

Re-evaluation of the functional anatomy of the basal ganglia in normal and Parkinsonian states

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-510X%2899%2900141-0

The current model of basal ganglia organization under scrutiny

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-510X%2899%2900141-0

Pallidotomy: a survey of current practice in North America.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-510X%2899%2900141-0